Form 4: Synaptogenix Director William S. Singer Acquires Stock Options

Director William S. Singer acquired stock options in Synaptogenix, Inc. on April 8, 2024.

Summary

• On April 8, 2024, William S. Singer, a director of Synaptogenix, Inc. (SNPX), acquired stock options.
• The options grant the right to buy 800 shares of common stock at an exercise price of $5.39.
• The options vest after one year of service from April 8, 2024, and expire on April 8, 2034.
• Following the transaction, Singer directly owns 800 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing related to stock option grants. It doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders, providing transparency into their transactions in company stock. This is a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from a company director.

Key Dates

Keywords

Synaptogenix, Director, Stock Options, Form 4, Beneficial Ownership, SNPX, Securities